Table 2.
The frequency of symptoms in individuals with and without SARS-CoV-2-reactive IgG at the time of diagnosis and the time of symptom onset
| Symptoms | 1st IgG test | p* | ||
|---|---|---|---|---|
| N | Reactive n = 125 n (%) |
Nonreactive n = 10 n (%) |
||
| Fever | 84 | 76 (60.8) | 7 (70.0) | 0.7405 |
| Headache | 94 | 88 (70.4) | 6 (60.0) | 0.4911 |
| Coryza | 62 | 59 (47.2) | 3 (30.0) | 0.3422 |
| Cough | 85 | 79 (63.2) | 6 (60.0) | 0.9994 |
| Sore throat | 73 | 66 (52.8) | 7 (70.0) | 0.3422 |
| Body pain | 94 | 89 (71.2) | 5 (50.0) | 0.2818 |
| Abdominal pain | 32 | 32 (25.6) | 0 (0.0) | 0.1165 |
| Diarrhea | 62 | 58 (46.4) | 4 (40.0) | 0.7532 |
| Vomiting | 16 | 16 (12.8) | 0 (0.0) | 0.3681 |
| Nausea | 37 | 37 (29.6) | 0 (0.0) | 0.0614 |
| Anosmia | 95 | 90 (72.0) | 5 (50.0) | 0.1640 |
| Ageusia | 91 | 86 (68.8) | 5 (50.0) | 0.2939 |
| Shortness of breath | 60 | 58 (46.4) | 2 (20.0) | 0.1843 |
| Hair loss | 47 | 44 (35.2) | 3 (30.0) | 1.0000 |
| Duration of symptoms | ||||
| ≤ 7 days | 43 | 40 (32.0) | 3 (30.0) | 1.0000 |
| 15 days | 43 | 39 (31.2) | 4 (40.0) | 0.7253 |
| ≥ 21 days | 46 | 44 (35.2) | 2 (20.0) | 0.4936 |
| No symptoms | 03 | 2 (1.6) | 1 (10.0) | 0.2073 |
*Fisher’s exact test